BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Shriners Burns Institute

Below is an extended Shriners Burns Institute research listing. Click here to return to the Shriners Burns Institute main Biocorporate entry.

Recent Publications by Shriners Burns Institute:

Pretreatment with the Gram-positive bacterial cell wall molecule peptidoglycan improves bacterial clearance and decreases inflammation and mortality in mice challenged with Staphylococcus aureus.
OBJECTIVE:: To determine whether tolerance and enhancement of innate...
1st October, 2008
From the Department of Anesthesiology (EDM, GF, ERS) and Shriners Burns Crit Care Med. 2008 Sep 26.
DOI Direct Link
Intracellular cytokines.
The principal technique described in this unit was developed for detecting...
5th September, 2008
University of Cincinnati College of Medicine and Shriners Burns Institute, Curr Protoc Cytom. 2004 May;Chapter 9:Unit 9.9.
DOI Direct Link
Pretreatment with the Gram-positive bacterial cell wall molecule peptidoglycan improves bacterial clearance and decreases inflammation and mortality in mice challenged with Pseudomonas aeruginosa.
The objective of this study was to determine if inflammatory tolerance and...
6th August, 2008
Department of Anesthesiology, University of Texas Medical Branch, 301 Microbes Infect. 2008 Jul 17.
DOI Direct Link
Proton NMR spectroscopy shows lipids accumulate in skeletal muscle in response to burn trauma-induced apoptosis.
Burn trauma triggers hypermetabolism and muscle wasting via increased...
7th March, 2006
Department of Surgery, Massachusetts General Hospital, Shriners Burns FASEB J. 2005 Sep;19(11):1431-40.
DOI Direct Link
Noninvasive magnetic resonance spectroscopic imaging biomarkers to predict the clinical grade of pediatric brain tumors.
The diagnosis and therapy of childhood brain tumors, most of which are low...
1st October, 2005
Nuclear Magnetic Resonance Surgical Laboratory, Department of Surgery, Clin Cancer Res. 2004 Dec 15;10(24):8220-8.
DOI Direct Link
Analysis of Pseudomonas aeruginosa 4-hydroxy-2-alkylquinolines (HAQs) reveals a role for 4-hydroxy-2-heptylquinoline in cell-to-cell communication.
Bacterial communities use "quorum sensing" (QS) to coordinate their...
10th March, 2004
Department of Surgery, Harvard Medical School and Shriners Burns Proc Natl Acad Sci U S A. 2004 Feb 3;101(5):1339-44. Epub 2004 Jan 22.
DOI Direct Link
Opposite effects of prostacyclin on hepatic blood flow and oxygen consumption after burn and sepsis.
BACKGROUND: Burn and sepsis are associated with hepatic ischemia and...
24th January, 2004
Shriners Burns Institute and the University of Texas Medical Branch, Ann Surg. 2004 Jan;239(1):67-74.
DOI Direct Link
The Drosophila melanogaster toll pathway participates in resistance to infection by the gram-negative human pathogen Pseudomonas aeruginosa.
Pseudomonas aeruginosa is a gram-negative pathogen that infects...
23rd July, 2003
Department of Surgery, Harvard Medical School and Massachusetts General Infect Immun. 2003 Jul;71(7):4059-66.
Multiparametric MR assessment of pediatric brain tumors.
MR assessment of pediatric brain tumors has expanded to include...
9th April, 2003
NMR Surgical Laboratory, Massachusetts General Hospital and Shriners Burns Neuroradiology. 2003 Jan;45(1):1-10. Epub 2002 Nov 20.
DOI Direct Link
Effects of interleukin-1alpha administration on intestinal ischemia and reperfusion injury, mucosal permeability, and bacterial translocation in burn and sepsis.
OBJECTIVE: To evaluate the effect of interleukin-1alpha (IL-1alpha) on the...
17th January, 2003
Shriners Burns Ann Surg. 2003 Jan;237(1):101-9.
DOI Direct Link

«Shriners Burns Institute

This page contained an extended Shriners Burns Institute research listing. Click here to return to the Shriners Burns Institute main Biocorporate entry.

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.